Lobbying340B Health lobbying by quarter
340B Health's latest lobbying report covers Q3 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $1.3M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Pharmacy.
340B Health
- Latest quarter
- $30K
- Q3 2026 · 1 reports
- Last 12 months
- $1.3M
- Last 4 quarters
- vs last quarter
- −92.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $320.6K | 6 |
| Q1 2023 | $412.4K | 6 |
| Q2 2023 | $509.7K | 6 |
| Q3 2023 | $433.5K | 5 |
| Q4 2023 | $344.6K | 5 |
| Q1 2024 | $496.2K | 5 |
| Q2 2024 | $420.1K | 5 |
| Q3 2024 | $440.5K | 5 |
| Q4 2024 | $335K | 5 |
| Q1 2025 | $496.1K | 6 |
| Q2 2025 | $505.5K | 6 |
| Q3 2025 | $498.6K | 6 |
| Q4 2025 | $409.3K | 6 |
| Q1 2026 | $471.2K | 6 |
| Q2 2026 | $374K | 6 |
| Q3 2026 | $30K | 1 |
By issue
- Pharmacy$5M · 45 reports
- Health issues$1.2M · 64 reports
- Medicare and Medicaid$280K · 23 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES82 reports
- SENATE68 reports
- Health Resources & Services Administration (HRSA)39 reports
- Health & Human Services, Dept of (HHS)27 reports
- Centers For Medicare and Medicaid Services (CMS)24 reports
- Office of Management & Budget (OMB)13 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-house340B Health | $4.7M | 15 quarters |
| Waxman Strategies | $639K | 15 quarters |
| McDermott+ | $540K | 16 quarters |
| Veritas Health Policy | $245K | 6 quarters |
| Bass Berry & Sims | $240K | 15 quarters |
| KD Government Relations | $71.6K | 3 quarters |
| Ray Anderson | $60K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DEBRA CURTIS | 1998-2013: Legislative Director, Chief of Staff, Rep. Pete Stark; jointly Professional Staff on Committee on Ways and Means, Health Subcommittee | Q3 2026 |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood | Q3 2026 |
| HENRY WAXMAN | US House of Representatives 1975 to 2015 | Q2 2026 |
| JEFFREY IRVING DAVIS | Former U.S. House Legislative Assistant | Q2 2026 |
| JEREMY SHARP | LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17 | Q2 2026 |
| AMY KELBICK | 2015-2017: Senior Policy Advisor, Rep. Jan Schakowsky; 2013-2015: Senior Legislative Assistant, Rep. Bill Foster; 2009-2013: Legislative Assistant, Staff Assistant, Rep. Maurice Hinchey | Q4 2025 |
| JOSH JORGENSEN | 2017-2020: Senior Legislative Correspondent; Legislative Aide, Sen. Mike Rounds | Q4 2025 |
| JULIA GRABO | 2021: Paid Intern, Rep. Colin Allred | Q4 2025 |
| MADALYN NEWS | 2020: Paid Intern, Rep. Madeleine Dean | Q4 2025 |
| LEIGH FELDMAN | 2016-2017: Senate Finance Committee (Detailee) | Q2 2025 |
| MARGARET GILLEY | 2005-2010: Executive Assistant, Legislative Assistant, Senior Policy Advisor, Rep. Jack Kingston | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 09/22for Q3 | Cozen O'Connor Public Strategies | Under $5,000 |
| 08/28for Q3 | McDermott+ | $30K |
| 07/27for Q2 | Ray Anderson | Under $5,000 |
| 07/20for Q2 | Veritas Health Policy | $45K |
| 07/20for Q2 | In-house | $240K |
| 07/14for Q2 | Waxman Strategies | $39K |
| 07/10for Q2 | Bass Berry & Sims | $10K |
| 07/06for Q2 | McDermott+ | $40K |
| 05/05for Q1 | Bass Berry & Sims | $10K |
| 04/20for Q1 | Ray Anderson | Under $5,000 |
| 04/20for Q1 | Waxman Strategies | $39K |
| 04/20for Q1 | Waxman Strategies | $25K |
| 04/17for Q1 | Veritas Health Policy | $45K |
| 04/10for Q1 | McDermott+ | $40K |
| 04/09for Q1 | In-house | $337.2K |
| 02/17for Q4 2025 | Ray Anderson | Under $5,000 |
| 01/20for Q4 2025 | In-house | $285.3K |
| 01/19for Q4 2025 | Veritas Health Policy | $45K |
| 01/13for Q4 2025 | Waxman Strategies | $39K |
| 01/08for Q4 2025 | McDermott+ | $40K |